BACKGROUND: A radioactively labeled beta-methyl branched fatty acid analog, 123I-15-(p-iodophenyl)-3-methyl pentadecanoic acid (BMIPP), has been developed to probe regional myocardial fatty acid metabolism. However, the significance of BMIPP uptake in the myocardium remains unclear. METHODS AND RESULTS: To evaluate the significance of BMIPP uptake, single-photon emission computed tomography was performed 30 minutes after injection of BMIPP, and 201Tl-labeled single-photon emission computed tomography was taken on a separate day in 10 patients. Findings of BMIPP and 201Tl-labeled imaging were compared with the data obtained from positron emission tomography with 11C-labeled palmitate. The BMIPP uptake (percent of maximum) was significantly correlated with the early uptake (percent) and delayed uptake (percent) of 11C-labeled palmitate (r = 0.659 and r = 0.687, respectively) (p < 0.01 each), whereas it was not significantly correlated with the residual fraction (r = 0.205) or the clearance half-time of the early component (r = 0.138) of 11C-labeled palmitate as a marker of beta-oxidation of the fatty acid. CONCLUSIONS: These data indicate that, although the myocardial uptake of BMIPP may not directly reflect beta-oxidation of fatty acids, its uptake may reflect both regional myocardial blood flow and fatty acid extraction.
BACKGROUND: A radioactively labeled beta-methyl branched fatty acid analog, 123I-15-(p-iodophenyl)-3-methyl pentadecanoic acid (BMIPP), has been developed to probe regional myocardial fatty acid metabolism. However, the significance of BMIPP uptake in the myocardium remains unclear. METHODS AND RESULTS: To evaluate the significance of BMIPP uptake, single-photon emission computed tomography was performed 30 minutes after injection of BMIPP, and 201Tl-labeled single-photon emission computed tomography was taken on a separate day in 10 patients. Findings of BMIPP and 201Tl-labeled imaging were compared with the data obtained from positron emission tomography with 11C-labeled palmitate. The BMIPP uptake (percent of maximum) was significantly correlated with the early uptake (percent) and delayed uptake (percent) of 11C-labeled palmitate (r = 0.659 and r = 0.687, respectively) (p < 0.01 each), whereas it was not significantly correlated with the residual fraction (r = 0.205) or the clearance half-time of the early component (r = 0.138) of 11C-labeled palmitate as a marker of beta-oxidation of the fatty acid. CONCLUSIONS: These data indicate that, although the myocardial uptake of BMIPP may not directly reflect beta-oxidation of fatty acids, its uptake may reflect both regional myocardial blood flow and fatty acid extraction.
Authors: H R Schelbert; E Henze; R Keen; H R Schon; H Hansen; C Selin; S C Huang; J R Barrio; M E Phelps Journal: Am Heart J Date: 1983-10 Impact factor: 4.749
Authors: H R Schön; H R Schelbert; G Robinson; A Najafi; S C Huang; H Hansen; J Barrio; D E Kuhl; M E Phelps Journal: Am Heart J Date: 1982-04 Impact factor: 4.749
Authors: H R Schön; R Senekowitsch; D Berg; M Schneidereit; G Reidel; H Kriegel; H W Pabst; H Blömer Journal: J Nucl Med Date: 1986-09 Impact factor: 10.057
Authors: C Kurata; K Tawarahara; T Taguchi; S Aoshima; A Kobayashi; N Yamazaki; H Kawai; M Kaneko Journal: J Nucl Med Date: 1992-01 Impact factor: 10.057
Authors: M Schwaiger; H R Schelbert; D Ellison; H Hansen; L Yeatman; J Vinten-Johansen; C Selin; J Barrio; M E Phelps Journal: J Am Coll Cardiol Date: 1985-08 Impact factor: 24.094
Authors: K Yamamoto; P Som; A B Brill; Y Yonekura; S C Srivastava; G E Meinken; J Iwai; M M Goodman; F F Knapp; D R Elmaleh Journal: J Nucl Med Date: 1986-07 Impact factor: 10.057
Authors: T Hirai; R Nohara; S Ogoh; L G Chen; K Kataoka; X H Li; M Fujita; A Matsumori; S Taguchi; S Sasayama Journal: J Nucl Cardiol Date: 2001 Jul-Aug Impact factor: 5.952
Authors: N Tamaki; E Tadamura; T Kudoh; N Hattori; Y Yonekura; R Nohara; S Sasayama; K Ikekubo; H Kato; J Konishi Journal: Eur J Nucl Med Date: 1996-03